Medicine Supply Notification: VFEND (Voriconazole) 40mg/ml powder for oral suspension – Updated
Update (13/05/2021): Resupply is now delayed
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for VFEND (Voriconazole) 40mg/ml powder for oral suspension
MSN/2021/016
Tier 2 – medium impact
Date of issue: 25/03/2021
- Voriconazole 40mg/ml powder for oral suspension is out of stock until late April 2021.
- Patients in primary care with insufficient supply who need continued treatment, should be referred back to secondary care for review.
- Voriconazole 50mg, 100mg and 200mg tablets remain available.
- Unlicensed supplies of voriconazole 40mg/ml oral suspension can be sourced.
The following specialist importers have confirmed they can source unlicensed voriconazole 40mg/ml oral suspension, please note there may be other companies that can also source supplies.
If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for unlicensed voriconazole 40mg/ml oral suspension cannot be issued. Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘voriconazole 40mg/ml oral suspension (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:
- Amount dispensed over pack size used;
- Invoice price per pack size from which the order was supplied less any discount or rebate;
- Manufacturers’/importers’ MHRA licence number;
- Batch number of the product supplied;
- SP
The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
